2020, ' Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 8, pp. 651-660 . https://doi.org/10.1016/S1474-4422(20)30207-6
Wardlaw, J M, von Kummer, R, Carpenter, T, Parsons, M, Lindley, R I, Cohen, G, Murray, V, Kobayashi, A, Peeters, A, Chappell, F & Sandercock, P A G 2015, ' Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke ', International Journal of Stroke, vol. 10, no. 6, pp. 956-968 . https://doi.org/10.1111/j.1747-4949.2012.00946.x
Lancet Wardlaw, J M, Murray, V, Berge, E, del Zoppo, G, Sandercock, P, Lindley, R L & Cohen, G 2012, ' Recombinant tissue plasminogen activator for acute ischaemic stroke : an updated systematic review and meta-analysis ', The Lancet, vol. 379, no. 9834, pp. 2364-72 . https://doi.org/10.1016/S0140-6736(12)60738-7
Trials Mead, G, Hackett, M L, Lundstrom, E, Murray, V, Hankey, G J & Dennis, M 2015, ' The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke : a study protocol for three multicentre randomised controlled trials ', Trials, vol. 16, 369 . https://doi.org/10.1186/s13063-015-0864-1